International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
S Kumar, B Paiva, KC Anderson, B Durie… - The lancet …, 2016 - thelancet.com
Treatment of multiple myeloma has substantially changed over the past decade with the
introduction of several classes of new effective drugs that have greatly improved the rates …
introduction of several classes of new effective drugs that have greatly improved the rates …
Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International …
Summary The International Myeloma Working Group consensus aimed to provide
recommendations for the optimal use of 18 fluorodeoxyglucose (18 F-FDG) PET/CT in …
recommendations for the optimal use of 18 fluorodeoxyglucose (18 F-FDG) PET/CT in …
[HTML][HTML] European Myeloma Network guidelines for the management of multiple myeloma-related complications
E Terpos, M Kleber, M Engelhardt, S Zweegman… - …, 2015 - ncbi.nlm.nih.gov
Abstract The European Myeloma Network provides recommendations for the management
of the most common complications of multiple myeloma. Whole body low-dose computed …
of the most common complications of multiple myeloma. Whole body low-dose computed …
Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement
MA Dimopoulos, J Hillengass, S Usmani… - Journal of Clinical …, 2015 - ascopubs.org
Purpose The aim of International Myeloma Working Group was to develop practical
recommendations for the use of magnetic resonance imaging (MRI) in multiple myeloma …
recommendations for the use of magnetic resonance imaging (MRI) in multiple myeloma …
PET/MRI: where might it replace PET/CT?
EC Ehman, GB Johnson… - Journal of Magnetic …, 2017 - Wiley Online Library
Simultaneous positron emission tomography and MRI (PET/MRI) is a technology that
combines the anatomic and quantitative strengths of MR imaging with physiologic …
combines the anatomic and quantitative strengths of MR imaging with physiologic …
Whole-body imaging of multiple myeloma: diagnostic criteria
AG Ormond Filho, BC Carneiro, D Pastore, IP Silva… - Radiographics, 2019 - pubs.rsna.org
Multiple myeloma (MM) is a clonal plasma cell proliferative disorder characterized by
primary infiltration of bone marrow and excessive production of abnormal immunoglobulin …
primary infiltration of bone marrow and excessive production of abnormal immunoglobulin …
Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe)
C Nanni, A Versari, S Chauvie, E Bertone… - European journal of …, 2018 - Springer
Materials and methods Patients affected by symptomatic MM who had performed an FDG
PET/CT at baseline (PET0), after induction (PET-AI), and the end of treatment (PET-EoT) …
PET/CT at baseline (PET0), after induction (PET-AI), and the end of treatment (PET-EoT) …
Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe)
C Nanni, E Zamagni, A Versari, S Chauvie… - European journal of …, 2016 - Springer
Abstract Purpose FDG PET/CT is able to detect active disease in patients with multiple
myeloma (MM) and can be helpful for staging and assessing therapy response, but no …
myeloma (MM) and can be helpful for staging and assessing therapy response, but no …
clinical PET/MRI: 2018 update
OBJECTIVE. The purpose of this article is to provide an update on clinical PET/MRI,
including current and developing clinical indications and technical developments …
including current and developing clinical indications and technical developments …
[HTML][HTML] Imaging of multiple myeloma: Current concepts
T Derlin, P Bannas - World journal of orthopedics, 2014 - ncbi.nlm.nih.gov
Medical imaging is of crucial importance for diagnosis and initial staging as well as for
differentiation of multiple myeloma (MM) from other monoclonal plasma cell diseases …
differentiation of multiple myeloma (MM) from other monoclonal plasma cell diseases …